|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A randomized clinical trial of trimetazidine,apartial free fatty acid oxidation inhibitor,in patients with heart failure显示文摘 | Fragasso G Palloshi A Puccetti P | 2006 | J Am Coll Cardiol2006，48，： | 1 |
| 2 | A randomized clinical trial of trimetazidine,a partial free fatty acid oxidation inhibitor,in patients with heart failure显示文摘 | Fragasso G Palloshi A Puccetti P | 2006 | J Am Coll Cardiol2006，48，： | 1 |
| 3 | A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure 显示文摘 | Fragasso G Palloshi A Puccetti P | 2006 | J Am Coll Cardiol2006，48，5： | 1 |
| 4 | IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation 显示文摘 | Puccetti P Grohmann U | 2007 | Nat Rev lmmunol2007，7，： | 1 |
| 5 | A randomized clinical trial of trimetazidine,a partial free fatty acid oxidation inhibitor,in patients with heart failure显示文摘 | Fragasso G Palloshi A Puccetti P | | 0，，5： | 1 |
| 6 | Tolerance, DCs and tryptophan: much ado about IDO 显示文摘 | Grohmann U Fallarino F Puccetti P | 2003 | Trends Immunol2003，24，5： | 1 |
| 7 | A randomized clin- ical trial of trimetazidine, a partial free fatty acid oxidation in- hibitor, in patients with heart failure 显示文摘 | Fragasso G Palloshi A Puccetti P | 2006 | J Am Coll Cardiol2006，48，5： | 1 |
| 8 | Interleukin-12 in infections diseases 显示文摘 | Romani L Puccetti P Bistoni F | 1997 | Clin Microbiol Rev1997，10，4： | 1 |
| 9 | Toward the identification of a tolerogenic signature in IDO-competent dendritic cells 显示文摘 | Orabona C Puccetti P Vacca C | 2006 | Blood2006，107，7： | 1 |
| 10 | Tolerance, DCs and trypto-phan :Much ado about IDO显示文摘 | Grohmann U Fallarino F Puccetti P | 2003 | Trends Immunol2003，24，5： | 1 |
| 11 | Biological role of Th cell subset in Candidiasis显示文摘 | Romani L Puccetti P Bistoni F | 1996 | Chem Immunol1996，63，： | 1 |
| 12 | IDO and regulatory T cells:a role forreverse signalling and non-canonical NF-kappaB activation显示文摘 | Puccetti P Grohmann U | 2007 | NatRev Immunol2007，7，10： | 1 |
| 13 | IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation 显示文摘 | Puccetti P Grohmann U | 2007 | Nat Rev Immunol2007，7，10： | 1 |
| 14 | A randomized clinical trial of trimetazidine,a partial free fatty acid oxidation inhib-itor,in patients with heart failure显示文摘 | Fragasso G Palloshi A Puccetti P | 2006 | J Am Coll Cardiol2006，48，21： | 1 |
| 15 | A randomized clinical trial of trimetazidine, a partial free fatty acid oxi- dation inhibitor, in patients with heart failure 显示文摘 | Fragasso G Palloshi A Puccetti P | 2006 | J Am Coil Cardiol2006，48，5： | 1 |
| 16 | Indoleamine 2,3- dioxygenase : from catalyst to signaling function显示文摘 | Fallarino F Grohmann U Puccetti P | 2012 | EurJ Immunol2012，42，8： | 1 |
| 17 | A randomized clinical trial of trimetazidine, a partial free fatty acid oxi- dation inhibitor, in patients with heart failure 显示文摘 | Fragasso G Palloshi A Puccetti P | 2006 | J Am Coll Cardiol2006，48，： | 1 |
| 18 | Tolerance, DCs and tryptophan: much ado about IDO显示文摘 | Grohmann U Fallarino F Puccetti P | 2003 | Trends Immunol2003，24，5： | 1 |
| 19 | Chronic granulomatousdisease 显示文摘 | Segal BH Romani L Puccetti P | 2009 | Cell Mol Life Sci2009，66，4： | 1 |
| 20 | Interleukin-12 in infectious diseases显示文摘 | Romani L Puccetti P Bistoni F | 1997 | Clin Microbiol Rev1997，10，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员